Parent Drug Name | Name of Impurity | Catalogue No. | |
---|---|---|---|
Solifenacin | N-formyl-2-phenyl-1, 2, 3, 4-tetrahydroisoquinoline | VE006246 | View CAS 80574-72-7 |
Solifenacin | Phenethylbenzamide of Solifenacin | VL131022 | View CAS 3278-14-6 |
Solifenacin | Phenyl (S)-1-Phenyl-3, 4-Dihydroisoquinoline-2(1H)-Carboxylate | VL131016 | View |
Solifenacin | Phenyltetrahydroisoquinolin | VL131025 | View |
Solifenacin | S-(+)-3- Quinuclidinol | VE0011024 | View CAS 34583-34-1 |
Solifenacin | Solifenacin Benzoyl (S)-Quinuclidinyl Impurity | VE007937 | View |
Solifenacin | Solifenacin EP Impurity A | VL131001 | View CAS 118864-75-8 |
Solifenacin | Solifenacin EP Impurity B | VL131024 | View |
Solifenacin | Solifenacin EP Impurity C | VL131007 | View CAS 1534326-81-2 |
Solifenacin | Solifenacin EP Impurity D | VL131008 | View CAS 2216750-52-4 |
Solifenacin | Solifenacin EP Impurity E (HCl salt ) | VL131010 | View CAS 42437-96-7 |
Solifenacin | Solifenacin EP Impurity E (free base) | VL131023 | View CAS 25333-42-0 |
Solifenacin | Solifenacin EP Impurity F | VL131004 | View CAS 774517-20-3 |
Solifenacin | Solifenacin EP Impurity G | VL131005 | View CAS 740780-79-4 |
Solifenacin | Solifenacin EP Impurity G (Succinate Salt) | VE006833 | View CAS 862207-70-3 |
Solifenacin | Solifenacin EP Impurity H (HCl salt) | VL131006 | View CAS 180468-38-6 |
Solifenacin | Solifenacin EP Impurity I | VL131002 | View CAS 180272-28-0 |
Solifenacin | Solifenacin Hydroxyquinuclidine Impurity | VL131027 | View CAS 34583-34-1 |
Solifenacin | Solifenacin In house Impurity C | VL131003 | View CAS 180468-42-2 |
Solifenacin | Solifenacin Isomer Mixture | VL131009 | View |
Solifenacin | Solifenacin Nitrophenyl Ester Impurity | VL131011 | View CAS 1229227-22-8 |
Solifenacin | Solifenacin Nitroso Impurity | VE0010821 | View |
Solifenacin | Solifenacin Phenyl Tetrahydroisoquinoline Racemate | VE005863 | View CAS 22990-19-8 |
Solifenacin | Solifenacin Related Compound 19 | VL131014 | View |
Solifenacin | 4, 6-Dimethyl-2-(methylthio)pyrimidine | VE0010842 | View CAS 14001-64-0 |
Solifenacin | (R)-1-Phenyl-1, 2, 3, 4-tetrahydroisoquinoline | VE008433 | View CAS 180272-45-1 |
Solifenacin Related Compound
Solifenacin is categorized as an antimuscarinic (or anticholinergic) muscle relaxant. It works by relaxing the muscle present in the bladder’s wall. This helps to enhance the volume of urine your bladder can retain while also controlling pee discharge.
References
- Chilman Blair, K., and J. L. Bosch. “Solifenacin: Treatment of Overactive Bladder.” Drugs of Today, vol. 40, no. 4, 2004, p. 343, https://doi.org/10.1358/dot.2004.40.4.820080. Accessed 10 Mar. 2023.
- Salih, Elsayed M., et al. “The Efficacy of Alpha-1A Blocker (Tamsulosin), Antimuscarinic (Solifenacin) and Their Combination in the Management of Double-J Stent-Related Lower Urinary Tract Symptoms: A Randomized Controlled Study.” African Journal of Urology, vol. 27, no. 1, Feb. 2021, https://doi.org/10.1186/s12301-021-00142-0. Accessed 10 Mar. 2023.
- Yang, Yu-Wan, et al. “Association between Different Anticholinergic Drugs and Subsequent Dementia Risk in Patients with Diabetes Mellitus.” PLOS ONE, edited by Gianluigi Forloni, vol. 12, no. 4, Apr. 2017, p. e0175335, https://doi.org/10.1371/journal.pone.0175335. Accessed 10 Mar. 2023.
FAQ
What is the mechanism of action of solifenacin?
Solifenacin serves to reduce bladder activity by blocking the smooth muscle wall surrounding the bladder from contracting. Micturition is generally triggered by acetylcholine muscarinic M3 receptor activation in the detrusor muscle wall.
Does solifenacin function as an alpha blocker?
Monotherapy with an alpha-1A blocker (tamsulosin) or an antimuscarinic (solifenacin) improves the DJ stent-related LUTS and QoL of patients who do not benefit from either treatment.
Is solifenacin succinate an anticholinergic?
In the treatment of (Overactive bladder)OAB, solifenacin is an anticholinergic medication that uses muscarinic acetylcholine receptors to minimize spasmolytic effects on bladder smooth muscle.